KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $219.9 million.

  • Exact Sciences' Cash from Operations rose 5853.85% to $219.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $386.8 million, marking a year-over-year increase of 6599.81%. This contributed to the annual value of $210.5 million for FY2024, which is 3485.61% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Cash from Operations is $219.9 million, which was up 5853.85% from $89.0 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' Cash from Operations peaked at $219.9 million during Q3 2025, and registered a low of -$173.8 million during Q1 2022.
  • Its 5-year average for Cash from Operations is $20.0 million, with a median of $30.8 million in 2025.
  • In the last 5 years, Exact Sciences' Cash from Operations skyrocketed by 68714.7% in 2021 and then tumbled by 25101.77% in 2022.
  • Quarter analysis of 5 years shows Exact Sciences' Cash from Operations stood at -$24.6 million in 2021, then surged by 311.77% to $52.0 million in 2022, then surged by 33.65% to $69.5 million in 2023, then crashed by 32.33% to $47.1 million in 2024, then surged by 367.29% to $219.9 million in 2025.
  • Its Cash from Operations stands at $219.9 million for Q3 2025, versus $89.0 million for Q2 2025 and $30.8 million for Q1 2025.